|
Apr 24
|
When Will Liquidia Corporation (NASDAQ:LQDA) Become Profitable?
|
|
Apr 3
|
Liquidia Corporation (NASDAQ:LQDA) has caught the attention of institutional investors who hold a sizeable 38% stake
|
|
Apr 2
|
Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference
|
|
Apr 1
|
Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powder
|
|
Mar 20
|
Chief Medical Officer Rajeev Saggar Sells Shares of Liquidia Corp (LQDA)
|
|
Mar 20
|
Insider Sell: CFO and COO Michael Kaseta Sells 12,166 Shares of Liquidia Corp (LQDA)
|
|
Mar 16
|
Liquidia Corporation (NASDAQ:LQDA) Q4 2023 Earnings Call Transcript
|
|
Mar 14
|
Liquidia Full Year 2023 Earnings: Misses Expectations
|
|
Mar 14
|
Q4 2023 Liquidia Corp Earnings Call
|
|
Mar 13
|
Liquidia Corp (LQDA) Reports Full Year 2023 Financial Results
|
|
Mar 13
|
Liquidia Technologies, Inc. (LQDA) Reports Q4 Loss, Lags Revenue Estimates
|
|
Mar 13
|
Liquidia Corporation Reports Full Year 2023 Financial Results and Provides Corporate Update
|
|
Mar 7
|
Earnings Preview: Pliant Therapeutics, Inc. (PLRX) Q4 Earnings Expected to Decline
|
|
Mar 6
|
Liquidia Corporation to Report Full Year 2023 Financial Results on Wednesday, March 13, 2024
|
|
Feb 22
|
United Therapeutics (UTHR) Q4 Earnings & Sales Beat Estimates
|
|
Feb 21
|
United Therapeutics' Challenges FDA Over Liquidia's Drug Approval Process, Clocks Strong Q4 Earnings
|
|
Feb 21
|
UPDATE 3-United Therapeutics starts litigation with FDA over rival Liquidia's drug application
|
|
Feb 21
|
United Therapeutics, in unusual step, sues FDA over rival’s drug application
|
|
Jan 9
|
Wall Street Analysts Believe Liquidia Technologies, Inc. (LQDA) Could Rally 29.94%: Here's is How to Trade
|
|
Jan 9
|
What Makes Liquidia Technologies, Inc. (LQDA) a Strong Momentum Stock: Buy Now?
|